Details for New Drug Application (NDA): 074726

NDA 074726 describes KLOR-CON M20, which is a drug marketed by Upsher Smith Labs and is included in one NDA. It is available from nine suppliers. Additional details are available on the KLOR-CON M20 profile page.

The generic ingredient in KLOR-CON M20 is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-seven suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

Summary for 074726

Tradename:	KLOR-CON M20
Applicant:	Upsher Smith Labs
Ingredient:	potassium chloride
Patents:	0

Pharmacology for NDA: 074726

Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

Suppliers and Packaging for NDA: 074726

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
KLOR-CON M10	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	074726	ANDA	Upsher-Smith Laboratories, LLC	0245-5317	0245-5317-01	100 BLISTER PACK in 1 CARTON (0245-5317-01) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0245-5317-89)
KLOR-CON M10	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	074726	ANDA	Upsher-Smith Laboratories, LLC	0245-5317	0245-5317-10	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0245-5317-10)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	20MEQ
Approval Date:	Nov 20, 1998	TE:	AB1	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	10MEQ
Approval Date:	Aug 9, 2000	TE:	AB1	RLD:	No

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	15MEQ
Approval Date:	Jun 6, 2003	TE:	AB1	RLD:	No

Complete Access Available with Subscription